Tag: #FGF23
-
The Impact of Interdialytic Weight Gain on Cardiovascular Health in Hemodialysis Patients
Introduction: Patients undergoing hemodialysis often experience significant volume shifts that can impact cardiovascular health. A recent study explores how interdialytic weight gain (IDWG) correlates with left ventricular hypertrophy (LVH) and fibroblast growth factor 23 (FGF-23) in end-stage renal disease (ESRD) patients. Understanding these relationships is crucial for improving patient outcomes. Visit https://www.clinnephrologyjournal.org/jcn for more insights…
-
Circulating Levels of Fibroblast Growth Factor 23 in Hemodialysis Patients
Introduction: Fibroblast Growth Factor 23 (FGF23) plays a crucial role in regulating phosphate metabolism and has been linked to cardiovascular complications in hemodialysis patients. A recent study published in the Journal of Clinical Nephrology explores the cleavage characteristics of FGF23 and its implications for chronic kidney disease (CKD) patients undergoing hemodialysis. Visit Journal of Clinical…
Heighten Science Publications Inc. 